Abridge vs Aidoc
A detailed comparison to help you choose between Abridge and Aidoc.
⚖️
How to choose
Neither tool has user reviews on ToolSpotter yet, so we don't pick a winner. Compare them on what they're built for: Abridge — Large US health systems on Epic standardising ambient documentation across thousands of clinicians, with the integration staff and budget for a multi-year enterprise rollout.; Aidoc — Hospital radiology departments and integrated health systems with meaningful acute imaging volumes that want one governed platform for many FDA-cleared triage algorithms instead of a stack of point solutions..
Abridge AI-powered healthcare documentation and clinical conversations | Aidoc AI powered radiology image analysis platform | |
|---|---|---|
| Rating | 4.2 (1 review) | 4.2 (1 review) |
| Pricing Model | paid | paid |
| Starting Price | From $99/mo | From $10000/mo |
| Best For | Large US health systems on Epic standardising ambient documentation across thousands of clinicians, with the integration staff and budget for a multi-year enterprise rollout. | Hospital radiology departments and integrated health systems with meaningful acute imaging volumes that want one governed platform for many FDA-cleared triage algorithms instead of a stack of point solutions. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | api accessteam featuresgdpr compliant | api accessteam featuresgdpr compliant |
| Visit Abridge → | Visit Aidoc → |
Abridge
Pros
- + Linked Evidence maps each note sentence back to the source audio moment — in my evaluation the click-through verification loop made spot-checking a note take seconds per section, the fastest trust mechanism in the category
- + Deepest Epic integration available: Abridge Inside runs across Haiku, Canto, Hyperdrive and the ASAP emergency module with bidirectional note sync and no app-switching
- + Platform expansion is coherent rather than scattershot — revenue-cycle coding documentation, nursing notes, Outpatient Orders, prior authorisation via Highmark/Availity, and NEJM/JAMA-backed decision support
- + Best in KLAS for Ambient AI in both 2025 and 2026, with named wall-to-wall deployments at Kaiser Permanente, Mayo, Johns Hopkins, Duke and UPMC
- + Financially durable: roughly $812–830M raised, a $5.3B valuation as of the April 2026 extension, and NVIDIA/Eli Lilly partnerships extending the model layer
Cons
- - Enterprise-only: no self-serve signup, no free trial, no public pricing; third-party estimates (~$2,500/clinician/year) are guesses against multi-year negotiated contracts
- - Deployment is a weeks-to-months Epic integration project — the full feature set is thinnest outside Epic environments
- - Epic is both distribution engine and competitor: the Workshop co-development program ended and Epic now ships its own native ambient scribe
- - Vendor-reported outcomes (60–86% documentation time reduction, ~55% burnout reduction) are health-system/vendor figures without independent standardised benchmarks
- - New data uses — revenue-cycle coding, trial screening with Eli Lilly — raise data-minimisation and governance questions that each health system must settle locally
Aidoc
Pros
- + Widest FDA-cleared acute triage portfolio I have reviewed: 31 authorisations on the FDA's December 2025 list, plus the first multi-indication clearance covering 14 abdominal CT findings in one workflow
- + Multi-triage consolidation meaningfully reduces alert noise — one flagged study produces one stacked panel, not one pop-up per algorithm
- + Real-world deployment evidence: Mercy Health documented urgent case turnaround falling from 19.8h to 1.3h across 50+ hospitals, with 5,642 patients expedited from 50,749 flagged findings
- + Vendor-neutral aiOS layer lets a health system run third-party and Aidoc algorithms through one governance and notification stack (17 FDA-cleared algorithms deployed at Hartford HealthCare)
- + Care Coordination and Patient Management close the loop beyond triage: mobile alerts with image context, and report mining that routes incidental findings to facility-defined follow-up protocols
Cons
- - No public pricing, no trial, no free tier — third-party estimates of ~$50k/site/year baseline with $8k-$15k per extra module are unverifiable until you are deep in a sales process
- - Hospital-only: requires PACS/RIS/EHR integration work, so it is irrelevant to individual clinicians, small practices and low-volume facilities
- - 510(k) clearance for most modules does not itself require independent clinical performance data (per JAMA Network Open) — buyers should demand the study set, not just the clearance count
- - No public changelog for algorithm updates, which is a real gap for a system whose output feeds clinical decisions
- - Vendor performance figures (order-of-magnitude false-alert reduction, 1,600+ hospitals) are company claims I could not independently audit
Frequently Asked Questions
Which is better, Abridge or Aidoc?▼
It depends on your specific needs — neither tool has user reviews on ToolSpotter yet, so we don't rank one above the other. Abridge is best for: Large US health systems on Epic standardising ambient documentation across thousands of clinicians, with the integration staff and budget for a multi-year enterprise rollout.. Aidoc is best for: Hospital radiology departments and integrated health systems with meaningful acute imaging volumes that want one governed platform for many FDA-cleared triage algorithms instead of a stack of point solutions..
What is the difference between Abridge and Aidoc?▼
Abridge: Abridge listens to clinical conversations and produces structured notes for the medical record, used across hospital systems. Aidoc: Aidoc analyses medical imaging to flag urgent findings for radiologists and care teams, prioritising the cases that need attention first.
Is Abridge or Aidoc more affordable?▼
Abridge starts at €99/mo, Aidoc starts at €10000/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.